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Purpose or Objective: Interobserver variation in target 
definition is a major contributor to geometric uncertainty in 
radiotherapy and consistent GTV delineation is crucial in dose 
escalation studies for oesophageal cancer. The routine use of 
FDG-PET for target delineation in oesophageal cancer 
patients treated with chemoradiation is debated in the 
literature. The aims of this study were to evaluate the 
interobserver variation of GTV delineation in The Netherlands 
and the impact of adding FDG-PET to CT images on 
interobserver variability in patients with oesophageal 
carcinoma. 
 
Material and Methods: Six cases were included from a 
prospective database of oesophageal carcinoma patients. All 
cases underwent a planning FDG-PET/CT scan in treatment 
position. Twenty upper gastro-intestinal dedicated radiation 
oncologists from 14 institutes in The Netherlands 
independently delineated the GTV first on CT, using 
additional clinical and diagnostic information. Secondly, they 
adjusted this GTV after CT and FDG-PET images were fused. 
As general metrics for interobserver variability, volumes and 
generalized conformity indices were calculated. For visual 
comparison of interobserver variation observer count maps 
were generated for each case, i.e. maps of voxels showing 
the number of enclosing observer delineations. To quantify 
the interobserver variation at the cranial and caudal border, 
the distance along the z-axis that contains 5-95% of the 
observers was used. 
 
Results: Significant differences in delineated GTV volumes 
were observed in 4 out of 6 cases after addition of FDG-PET 
to CT (Table 1). In 3 cases there was a significant volume 
reduction, whereas in one case a significant volume increase 
was found by PET, caused by unsuspected continuation of the 
tumour in the stomach. Generalized conformity indices were 
comparable for CT and FDG-PET/CT (Table 1). Count maps 
revealed that interobserver variation was mainly located at 
the cranial and caudal border (Figure 1A). The median 
observer variation was 26 mm (range 6-36 mm) at the cranial 
border and 18 mm (range 3-30 mm) at the caudal border 
(Figure 1B). Even after addition of PET interobserver 
variation remained more than 20 mm in 4 out of 6 cases 
(Figure 1B). In 2 cases a reduced interobserver variation was 
seen with PET/CT at the cranial border and in another 2 
cases only at the caudal border. An increased variation was 
seen with PET/CT compared with CT at the caudal border for 
the case with the unsuspected FDG uptake in the stomach. 
 
 
 
 
Conclusion: This nationwide Dutch contouring study in 
oesophageal cancer demonstrated that in daily clinical 
practice considerable GTV delineation variation is present, 
with variations up to 36 and 30 mm at the cranial and caudal 
border, respectively. Although FDG-PET significantly 
impacted the delineated volume in two-thirds of the 
patients, the addition of PET did not translate into an 
observer variation below 20 mm in 4 out of 6 cases. 
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Purpose or Objective: In pancreatic cancer, the delineation 
of target volumes on a CT scan can be difficult due to poor 
contrast between tumour and surrounding tissues. This study 
quantifies, for pancreatic cancer in the Netherlands, the 
interobserver variation of delineated gross tumour volume 
(GTV) and the internal GTV (iGTV: the volume encompassing 
GTV in all ten phases of the respiratory cycle) on three-
dimensional CT (3DCT) and four-dimensional-CT (4DCT), 
respectively. 
 
Material and Methods: Seven radiation oncologists from six 
institutions, with an average of 5 irradiated pancreatic 
patients per year (range: 3–10), delineated pancreatic 
tumours in four patients with (borderline) resectable 
pancreatic cancer. First, the GTV was delineated on a 
contrast-enhanced 3DCT under guidance of an arterial and 
venous contrast-enhanced diagnostic scan. This contrast-
enhanced 3DCT scan was obtained during free breathing, 
using a GE LightSpeed RT16 scanner. The GTV was expanded 
with a fixed margin of 5 mm to create the CTV. In the same 
session, a 4DCT scan, without contrast enhancement, was 
obtained, during which the respiratory motion of the patient 
was monitored to reconstruct 10 respiratory phase scans. 
Second, the iGTV was delineated on the 4DCT, under 
guidance of the diagnostic CT and expanded with a fixed 
margin of 5 mm to create an iCTV. Also, a questionnaire 
concerning experience of the participating radiation 
oncologists was filled out. We calculated median volumes, 
encompassing volumes and common volumes of the GTV, 
iGTV, CTV and iCTV. In addition, the generalized conformity 
index (CIgen) and overall observer variation were calculated 
(value of 1 representing full agreement; 0 no agreement). 
Interobserver variation of 3DCT and 4DCT delineations were 
analysed and compared. 
 
Results: For all delineated and created volumes, the results 
of the mean median volumes, encompassing volumes, 
common volumes and CIgen over all four patients are 
presented in Table 1. The mean overall standard deviation 
(SD) (averaged over 4 patients) was 0.54 cm and 0.58 cm on 
3DCT and 4DCT, respectively. The CIgen was smaller for 
4DCT, indicating larger variations in delineation on 4DCT. 
Typical differences in delineations between the seven 
observers are presented in Fig. 1. The radiation oncologists 
experienced the GTV and iGTV delineations in this study as 
difficult. 
 
 
 
 
Conclusion: A considerable interobserver variation in 
delineation of pancreatic tumours was found, with a mean 
CIgen of 0.46 for 3DCT (GTV) and 0.35 for 4DCT (iGTV). This 
indicates a large variation in interpretation of diagnostic CT 
images and 4DCT images. The limited experience of the 
observers with delineation as well as the poor contrast 
between pancreatic cancer and surrounding tissues on CT 
imaging may have contributed to these results. This should 
be improved, perhaps by using additional imaging. 
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Purpose or Objective: Heterogeneity is a well recognised 
feature of malignancy that has been associated with adverse 
tumour biology (1). There is also initial evidence that it may 
be a potential prognostic biomarker for oesophageal cancer 
(2). Using texture analysis, the purpose of this study is to 
investigate the relationship between CT image heterogeneity 
and patient outcome in the SCOPE 1 UK wide multi-centre 
clinical trial on oesophageal cancer.  
 
 
 
Material and Methods: The planning CT images of 215 
patients from the SCOPE 1 clinical trial were uploaded to the 
TexRAD texture analysis software package. The original GTV 
outlines from the trial were imported on to the relevant 
DICOM CT images for each patient. Outcome data from the 
trial (Overall survival (OS) and progression free survival (PFS)) 
was included for analysis. Texture analysis of the area within 
